203 related articles for article (PubMed ID: 10391665)
21. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man.
Tingle MD; Mahmud R; Maggs JL; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1997 Nov; 283(2):817-23. PubMed ID: 9353403
[TBL] [Abstract][Full Text] [Related]
22. [Drug hydroxylation disorders (debrisoquin type) in a random sample of the Swiss population].
Dick B; Küpfer A; Molnàr J; Braunschweig S; Preisig R
Schweiz Med Wochenschr; 1982 Jul; 112(30):1061-7. PubMed ID: 7123181
[TBL] [Abstract][Full Text] [Related]
23. NTP technical report on the toxicity studies of a Chemical Mixture of 25 Groundwater Contaminants Administered in Drinking Water to F344/N Rats and B6C3F(1) Mice.
Yang R
Toxic Rep Ser; 1993 Aug; 35():1-I12. PubMed ID: 12209189
[TBL] [Abstract][Full Text] [Related]
24. Dapsone N-acetylation, metoprolol alpha-hydroxylation, and S-mephenytoin 4-hydroxylation polymorphisms in an Indonesian population: a cocktail and extended phenotyping assessment trial.
Setiabudy R; Kusaka M; Chiba K; Darmansjah I; Ishizaki T
Clin Pharmacol Ther; 1994 Aug; 56(2):142-53. PubMed ID: 8062490
[TBL] [Abstract][Full Text] [Related]
25. Validation of incorporating flurbiprofen into the Pittsburgh cocktail.
Zgheib NK; Frye RF; Tracy TS; Romkes M; Branch RA
Clin Pharmacol Ther; 2006 Sep; 80(3):257-63. PubMed ID: 16952492
[TBL] [Abstract][Full Text] [Related]
26. N-acetylation phenotyping using dapsone in a Jordanian population.
Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM
Br J Clin Pharmacol; 1991 Sep; 32(3):289-93. PubMed ID: 1777365
[TBL] [Abstract][Full Text] [Related]
27. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
[TBL] [Abstract][Full Text] [Related]
28. [Stability and/or variability of the expression of genetic polymorphism of hydroxylation and acetylation in patients with various pathologies and under various treatments].
Bechtel P; Joanne C; Bechtel Y; Grandmottet M; Jounet JM
Ann Biol Clin (Paris); 1986; 44(4):361-7. PubMed ID: 3538951
[TBL] [Abstract][Full Text] [Related]
29. Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population.
May DG; Porter J; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1994 May; 55(5):492-500. PubMed ID: 8181193
[TBL] [Abstract][Full Text] [Related]
30. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
[TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
32. Acetylation phenotype in colorectal carcinoma.
Ilett KF; David BM; Detchon P; Castleden WM; Kwa R
Cancer Res; 1987 Mar; 47(5):1466-9. PubMed ID: 3815349
[TBL] [Abstract][Full Text] [Related]
33. Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients.
Garg SK; Kumar B; Bakaya V; Lal R; Shukla VK; Kaur S
Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):552-4. PubMed ID: 3243659
[TBL] [Abstract][Full Text] [Related]
34. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
Grossman SJ; Jollow DJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994
[TBL] [Abstract][Full Text] [Related]
35. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
36. Acetylation phenotype is not associated with breast cancer.
Ilett KF; Detchon P; Ingram DM; Castleden WM
Cancer Res; 1990 Oct; 50(20):6649-51. PubMed ID: 2208127
[TBL] [Abstract][Full Text] [Related]
37. Neither dapsone hydroxylation nor cortisol 6beta-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors.
Gass RJ; Gal J; Fogle PW; Detmar-Hanna D; Gerber JG
Eur J Clin Pharmacol; 1998; 54(9-10):741-7. PubMed ID: 9923578
[TBL] [Abstract][Full Text] [Related]
38. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
39. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
40. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
